{"id":11438,"date":"2020-06-26T04:01:48","date_gmt":"2020-06-25T22:31:48","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?p=11438"},"modified":"2020-06-27T04:03:20","modified_gmt":"2020-06-26T22:33:20","slug":"fda-warns-of-newly-discovered-potential-drug-interaction","status":"publish","type":"post","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/","title":{"rendered":"FDA Warns of Newly Discovered Potential Drug Interaction"},"content":{"rendered":"

The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease.<\/p>\n

Revision in the fact sheet<\/h3>\n

According to the recent non-clinical laboratory study, the Food and Drug Administration (FDA) correcting the\u00a0fact sheet for health care providers<\/a>, which follows drug to state that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not advised as it can lead to the decreased antiviral activity of remdesivir. The FDA is unaware of incidences of this decreased activity happening in the clinical trial; however, it is continuing to assess all data linked to remdesivir.<\/p>\n

Additionally, the FDA amended the fact sheet for health care providers in order to explain administration guidance and dosing and to offer extra safety as well as supporting data from clinical trials performed by the National Institutes of Health as well as Gilead Sciences Inc., which is a drug sponsor. Apart from this, the\u00a0fact sheet for patients and caregivers\u00a0was too upgraded to add more information regarding probable allergic reactions and to inform patients and healthcare providers, whether they are consuming hydroxychloroquine sulfate or chloroquine phosphate.<\/p>\n

Safety and efficiency of remdesivir<\/h3>\n

According to the M.D., acting director of the FDA\u2019s Center for Drug Evaluation and Research, Patrizia Cavazzoni, said, \u201cDuring this uncommon COVID-19 crisis, the FDA has circulated emergency utilization authorizations for multiple medical products after assessing the existing scientific proof and critically adjusting any potential risks against the advantages of these products\u2019 availability, especially during this pandemic.<\/p>\n

Moreover, we know that with more product understanding, changes could be required depends on new data set like current updates for providers regarding a potential drug interaction and other essential information about the utilization of remdesivir in order to treat the COVID-19 patients.\u201d Further, Cavazzoni, said, \u201cthe FDA keeps to assess all of the emergency use authorizations circulated and their linked materials and will keep doing changes as required depends on evolving data and science\u201d<\/p>\n

Following an assessment of the emergency use authorization criteria and the scientific evidence available, in May 2020 the FDA issued an emergency use authorization (EUA) allowing for remdesivir to be distributed in the United States and to be managed intravenously by health care providers. Additionally, the usage of remdesivir should be appropriate in order to treat suspected or confirmed COVID-19 patients as well as to treat pediatric patients hospitalized with the critical disease. The safety and efficiency of the remdesivir for the COVID-19 treatment continue to be assessed, and primary clinical trial outcomes have showcase that on average, remdesivir treatment on COVID-19 patients had more fast time to recovery.<\/p>\n

Side effects of remdesivir<\/h3>\n

The\u00a0EUA<\/a>\u00a0needs that fact sheets regarding the utilization of remdesivir in treating COVID-19 should be provided to patients, healthcare providers, and caregivers. This fact sheets contain information about desirable side effects like allergic reactions, increased levels of liver enzymes, shortness of breath, high heart rate, rash, nausea, vomiting, sweating, low blood pressure, difficulty swallowing, shivering, respiratory distress, angioedema, low heart rate, and wheezing.<\/p>\n

We are one of the prominent medical billing and coding services providers<\/a> all over the country. Our dedicated team of billers and coders is working closely with our customers to offer maximum benefits. Our customer-driven billing and coding capabilities will mitigate the claim submission errors and help to increase your revenue performance. Fill free to contact us<\/a> and visit our website<\/a> to discover more about medical billing<\/a> and coding solutions.<\/p>\n","protected":false},"excerpt":{"rendered":"

The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease. Revision in the fact sheet According to the recent non-clinical laboratory study, the […]<\/p>\n","protected":false},"author":2,"featured_media":11439,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[746,921,922,80,747,30,359,778,737,738,46,47,751,198,419,15,417,162,724,9,11,64,16,339,146,192,753,754,418,144,815,816,699,86,904,58,34,27,785,758,763],"class_list":["post-11438","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-billing-services","tag-billing-services-for-doctors","tag-coronavirus","tag-covid-19","tag-cpt-codes","tag-cpthcpcs","tag-credentialing","tag-dme-billing-services","tag-dmepos","tag-e-m-codes","tag-e-m-services","tag-ehr","tag-emr-ehr-health-it","tag-hcpcs-code","tag-hospital-billing","tag-internal-medicine-billing","tag-medical-billing","tag-medical-billing-agencies","tag-medical-billing-and-coding-services","tag-medical-billing-audit","tag-medical-billing-companies","tag-medical-billing-outsourcing","tag-medical-billing-practices","tag-medical-billing-service","tag-medical-coding-audits","tag-medicare-2","tag-medicare-medicaid-services","tag-medicare-billing","tag-modifier","tag-online-medical-billing","tag-outsource-medical-billing","tag-outsourced-medical-billing-company","tag-outsourced-medical-billing-services","tag-outsourcing-primary-care-billing","tag-physician-billing","tag-prior-authorization","tag-rcm","tag-reimbursement","tag-revenue-cycle-management-2","tag-telehealth","tag-value-based-reimbursement","tag-wound-care-billing-services"],"yoast_head":"\nFDA Warns of Newly Discovered Potential Drug Interaction<\/title>\n<meta name=\"description\" content=\"The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Warns of Newly Discovered Potential Drug Interaction\" \/>\n<meta property=\"og:description\" content=\"The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Billing and RCM Blogs\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-25T22:31:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T22:33:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"748\" \/>\n\t<meta property=\"og:image:height\" content=\"280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Medical Billers and Coders\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Medical Billers and Coders\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/\"},\"author\":{\"name\":\"Medical Billers and Coders\",\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#\\\/schema\\\/person\\\/76d3509f0e1252992227e858251f1a8b\"},\"headline\":\"FDA Warns of Newly Discovered Potential Drug Interaction\",\"datePublished\":\"2020-06-25T22:31:48+00:00\",\"dateModified\":\"2020-06-26T22:33:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/\"},\"wordCount\":603,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/wp-content\\\/uploads\\\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg\",\"keywords\":[\"billing services for doctors\",\"Coronavirus\",\"COVID\u201319\",\"CPT codes\",\"CPT\\\/HCPCS\",\"Credentialing\",\"DME billing services\",\"DMEPOS\",\"E\\\/M Codes\",\"E\\\/M services\",\"EHR\",\"EMR \\\/ EHR \\\/ Health IT\",\"HCPCS Code\",\"Hospital Billing\",\"Internal Medicine billing\",\"Medical Billing\",\"medical billing Agencies\",\"medical billing and coding services\",\"medical billing audit\",\"medical billing companies\",\"medical billing outsourcing\",\"medical billing practices\",\"medical billing service\",\"medical coding audits\",\"medicare\",\"Medicare & Medicaid Services\",\"Medicare Billing\",\"Modifier\",\"online medical billing\",\"outsource Medical Billing\",\"outsourced medical billing company\",\"outsourced medical billing services\",\"outsourcing primary care billing\",\"physician billing\",\"Prior Authorization\",\"RCM\",\"Reimbursement\",\"revenue cycle management\",\"Telehealth\",\"value-based reimbursement\",\"wound care billing services\"],\"articleSection\":[\"Medical Billing Services\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#respond\"]}],\"copyrightYear\":\"2020\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/\",\"url\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/\",\"name\":\"FDA Warns of Newly Discovered Potential Drug Interaction\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/wp-content\\\/uploads\\\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg\",\"datePublished\":\"2020-06-25T22:31:48+00:00\",\"dateModified\":\"2020-06-26T22:33:20+00:00\",\"description\":\"The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/wp-content\\\/uploads\\\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg\",\"contentUrl\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/wp-content\\\/uploads\\\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg\",\"width\":748,\"height\":280,\"caption\":\"FDA Warns of Newly Discovered Potential Drug Interaction\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/fda-warns-of-newly-discovered-potential-drug-interaction\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Warns of Newly Discovered Potential Drug Interaction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/\",\"name\":\"Medical Billing and RCM Blogs\",\"description\":\"Medical Billing and Coding Services in USA\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#organization\"},\"alternateName\":\"MBC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\",\"ProfessionalService\"],\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#organization\",\"name\":\"Medical Billers and Coders\",\"alternateName\":\"MBC\",\"url\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/MBC-Square-Logo.png\",\"contentUrl\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/MBC-Square-Logo.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Billers and Coders\"},\"image\":{\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"telephone\":[\"888-357-3226\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"888-357-3226\",\"email\":\"info@medicalbillersandcoders.com\"},\"email\":\"sales@medicalbillersandcoders.com\",\"faxNumber\":\"888-316-4566\",\"currenciesAccepted\":\"$\",\"openingHoursSpecification\":[{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\"],\"opens\":\"08:00\",\"closes\":\"17:00\"},{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"00:00\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.medicalbillersandcoders.com\\\/blog\\\/#\\\/schema\\\/person\\\/76d3509f0e1252992227e858251f1a8b\",\"name\":\"Medical Billers and Coders\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3041c51926983b0f25500c647fc6164a5c96abebfa441f7f348298f70b360628?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3041c51926983b0f25500c647fc6164a5c96abebfa441f7f348298f70b360628?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3041c51926983b0f25500c647fc6164a5c96abebfa441f7f348298f70b360628?s=96&d=mm&r=g\",\"caption\":\"Medical Billers and Coders\"},\"description\":\"Catering to more than 40 specialties, Medical Billers and Coders (MBC) is proficient in handling services that range from revenue cycle management to ICD-10 testing solutions. The main goal of our organization is to assist physicians looking for billers and coders, at the same time help billing specialists looking for jobs, reach the right place.\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Warns of Newly Discovered Potential Drug Interaction","description":"The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/","og_locale":"en_US","og_type":"article","og_title":"FDA Warns of Newly Discovered Potential Drug Interaction","og_description":"The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease.","og_url":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/","og_site_name":"Medical Billing and RCM Blogs","article_published_time":"2020-06-25T22:31:48+00:00","article_modified_time":"2020-06-26T22:33:20+00:00","og_image":[{"width":748,"height":280,"url":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg","type":"image\/jpeg"}],"author":"Medical Billers and Coders","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Medical Billers and Coders","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#article","isPartOf":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/"},"author":{"name":"Medical Billers and Coders","@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#\/schema\/person\/76d3509f0e1252992227e858251f1a8b"},"headline":"FDA Warns of Newly Discovered Potential Drug Interaction","datePublished":"2020-06-25T22:31:48+00:00","dateModified":"2020-06-26T22:33:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/"},"wordCount":603,"commentCount":0,"publisher":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#primaryimage"},"thumbnailUrl":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg","keywords":["billing services for doctors","Coronavirus","COVID\u201319","CPT codes","CPT\/HCPCS","Credentialing","DME billing services","DMEPOS","E\/M Codes","E\/M services","EHR","EMR \/ EHR \/ Health IT","HCPCS Code","Hospital Billing","Internal Medicine billing","Medical Billing","medical billing Agencies","medical billing and coding services","medical billing audit","medical billing companies","medical billing outsourcing","medical billing practices","medical billing service","medical coding audits","medicare","Medicare & Medicaid Services","Medicare Billing","Modifier","online medical billing","outsource Medical Billing","outsourced medical billing company","outsourced medical billing services","outsourcing primary care billing","physician billing","Prior Authorization","RCM","Reimbursement","revenue cycle management","Telehealth","value-based reimbursement","wound care billing services"],"articleSection":["Medical Billing Services"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#respond"]}],"copyrightYear":"2020","copyrightHolder":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/","url":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/","name":"FDA Warns of Newly Discovered Potential Drug Interaction","isPartOf":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#primaryimage"},"image":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#primaryimage"},"thumbnailUrl":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg","datePublished":"2020-06-25T22:31:48+00:00","dateModified":"2020-06-26T22:33:20+00:00","description":"The United States Food and Drug Administration (FDA) is cautioning health care providers regarding the newly revealed potential drug interaction linked to inspectional antiviral drug remdesivir that has given emergency utilization authorization for the treatment of the COVID-19 patients with serious disease.","breadcrumb":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#primaryimage","url":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg","contentUrl":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/Blog-FDA-Warns-of-Newly-Discovered-Potential-Drug-Interaction.jpg","width":748,"height":280,"caption":"FDA Warns of Newly Discovered Potential Drug Interaction"},{"@type":"BreadcrumbList","@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/fda-warns-of-newly-discovered-potential-drug-interaction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.medicalbillersandcoders.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA Warns of Newly Discovered Potential Drug Interaction"}]},{"@type":"WebSite","@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#website","url":"https:\/\/www.medicalbillersandcoders.com\/blog\/","name":"Medical Billing and RCM Blogs","description":"Medical Billing and Coding Services in USA","publisher":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#organization"},"alternateName":"MBC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.medicalbillersandcoders.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place","ProfessionalService"],"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#organization","name":"Medical Billers and Coders","alternateName":"MBC","url":"https:\/\/www.medicalbillersandcoders.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/2025\/04\/MBC-Square-Logo.png","contentUrl":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-content\/uploads\/2025\/04\/MBC-Square-Logo.png","width":512,"height":512,"caption":"Medical Billers and Coders"},"image":{"@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#\/schema\/logo\/image\/"},"telephone":["888-357-3226"],"contactPoint":{"@type":"ContactPoint","telephone":"888-357-3226","email":"info@medicalbillersandcoders.com"},"email":"sales@medicalbillersandcoders.com","faxNumber":"888-316-4566","currenciesAccepted":"$","openingHoursSpecification":[{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday"],"opens":"08:00","closes":"17:00"},{"@type":"OpeningHoursSpecification","dayOfWeek":["Saturday","Sunday"],"opens":"00:00","closes":"00:00"}]},{"@type":"Person","@id":"https:\/\/www.medicalbillersandcoders.com\/blog\/#\/schema\/person\/76d3509f0e1252992227e858251f1a8b","name":"Medical Billers and Coders","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3041c51926983b0f25500c647fc6164a5c96abebfa441f7f348298f70b360628?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3041c51926983b0f25500c647fc6164a5c96abebfa441f7f348298f70b360628?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3041c51926983b0f25500c647fc6164a5c96abebfa441f7f348298f70b360628?s=96&d=mm&r=g","caption":"Medical Billers and Coders"},"description":"Catering to more than 40 specialties, Medical Billers and Coders (MBC) is proficient in handling services that range from revenue cycle management to ICD-10 testing solutions. The main goal of our organization is to assist physicians looking for billers and coders, at the same time help billing specialists looking for jobs, reach the right place."}]}},"_links":{"self":[{"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/posts\/11438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/comments?post=11438"}],"version-history":[{"count":3,"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/posts\/11438\/revisions"}],"predecessor-version":[{"id":11442,"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/posts\/11438\/revisions\/11442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/media\/11439"}],"wp:attachment":[{"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/media?parent=11438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/categories?post=11438"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.medicalbillersandcoders.com\/blog\/wp-json\/wp\/v2\/tags?post=11438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}